AU2002354041A1 - Antimnemonic therapy for hypermemory syndromes - Google Patents

Antimnemonic therapy for hypermemory syndromes

Info

Publication number: AU2002354041A1
Authority: AU; Australia
Prior art keywords: antimnemonic; hypermemory; syndromes; therapy; hypermemory syndromes
Prior art date: 2001-11-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002354041A

Inventor

John L. Haracz

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-06

Filing date

2002-11-05

Publication date

2003-05-19

2002-11-05 Application filed by Individual filed Critical Individual

2003-05-19 Publication of AU2002354041A1 publication Critical patent/AU2002354041A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2002354041A 2001-11-06 2002-11-05 Antimnemonic therapy for hypermemory syndromes Abandoned AU2002354041A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US33271301P	2001-11-06	2001-11-06
US60/332,713		2001-11-06
PCT/US2002/035524 WO2003039468A2 (en)	2001-11-06	2002-11-05	Antimnemonic therapy for hypermemory syndromes

Publications (1)

Publication Number	Publication Date
AU2002354041A1 true AU2002354041A1 (en)	2003-05-19

Family

ID=23299527

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002354041A Abandoned AU2002354041A1 (en)	2001-11-06	2002-11-05	Antimnemonic therapy for hypermemory syndromes

Country Status (3)

Country	Link
AU (1)	AU2002354041A1 (en)
CA (1)	CA2465869A1 (en)
WO (1)	WO2003039468A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7153256B2 (en)	2003-03-07	2006-12-26	Neuronetics, Inc.	Reducing discomfort caused by electrical stimulation
US8118722B2 (en)	2003-03-07	2012-02-21	Neuronetics, Inc.	Reducing discomfort caused by electrical stimulation
TW200531680A (en) *	2004-03-03	2005-10-01	Merz Pharma Gmbh & Co Kgaa	Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease
US7601115B2 (en)	2004-05-24	2009-10-13	Neuronetics, Inc.	Seizure therapy method and apparatus
ES2367868T3 (en) *	2004-09-20	2011-11-10	Mount Sinai School Of Medicine	USE OF MEMANTINE (NAMENDA) TO TREAT AUTISM, COMPULSIVITY AND IMPULSIVITY.
US7857746B2 (en)	2004-10-29	2010-12-28	Nueronetics, Inc.	System and method to reduce discomfort using nerve stimulation
US7396326B2 (en)	2005-05-17	2008-07-08	Neuronetics, Inc.	Ferrofluidic cooling and acoustical noise reduction in magnetic stimulators
US7824324B2 (en)	2005-07-27	2010-11-02	Neuronetics, Inc.	Magnetic core for medical procedures
WO2008045641A2 (en) *	2006-10-10	2008-04-17	The University Of Chicago	Composition s comprising a benzodiazepine, an alcohol aversive agent and an abuse aversive agent
US20110046120A1 (en) *	2006-10-26	2011-02-24	Mclean Hospital Corporation	Treatment of impulse control disorders
DK2872145T3 (en) *	2012-07-12	2022-06-13	Emalex Biosciences Inc	CONDENSED BENZAZE PINS FOR THE TREATMENT OF TOURETE'S SYNDROME
WO2016061320A2 (en) *	2014-10-15	2016-04-21	Rowan University	Timber therapy for post-traumatic stress disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2112487C (en) *	1991-06-26	2003-04-15	James W. Young	Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
US5338738A (en) *	1993-04-19	1994-08-16	Bristol-Myers Squibb Company	Cerebral function enhancers: acyclic amide derivatives of pyrimidinylpiperidines
US5863934A (en) *	1995-09-21	1999-01-26	Amy F. T. Arnsten	Use of lofexidine in the treatment of behavioral disorders

2002
- 2002-11-05 WO PCT/US2002/035524 patent/WO2003039468A2/en not_active Ceased
- 2002-11-05 CA CA002465869A patent/CA2465869A1/en not_active Abandoned
- 2002-11-05 AU AU2002354041A patent/AU2002354041A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2003039468A3 (en)	2003-10-23
WO2003039468B1 (en)	2003-11-27
CA2465869A1 (en)	2003-05-15
WO2003039468A2 (en)	2003-05-15

Publication	Publication Date	Title
AU2002310044A1 (en)	2002-12-09	Headwall
AU2002334359A1 (en)	2003-03-18	Language-acquisition apparatus
AU2002351574A1 (en)	2003-03-03	Improved self-chekout apparatus
AU2002229976A1 (en)	2002-09-04	Imidazopyridines
AU2002313565A1 (en)	2003-03-18	Putter-heads
AU2002356723A1 (en)	2003-06-10	Apparatus
AU2002354041A1 (en)	2003-05-19	Antimnemonic therapy for hypermemory syndromes
AU2002353739A1 (en)	2003-06-10	Therapeutic compounds
AU2002335667A1 (en)	2003-02-17	Modified reoviral therapy
AU2002226571A1 (en)	2002-08-12	Biligands
AU2001100406A4 (en)	2001-11-01	DriverSMS
AU2003202468A1 (en)	2003-07-24	Paper-binding and -folding apparatus
AU2002313073A1 (en)	2002-12-03	Phytocystatin
AU2002257925A1 (en)	2003-06-30	Numberplates
AUPR969801A0 (en)	2002-01-24	Therapeutic compounds - ii
AU2002332368A1 (en)	2003-03-10	Device for energoinformative therapy
AUPR693801A0 (en)	2001-09-06	Therapeutic compounds
AUPR964001A0 (en)	2002-01-24	Therapeutic compounds
AUPR817901A0 (en)	2001-11-01	Therapeutic compounds
AUPR640201A0 (en)	2001-08-09	For zero emmisions
AU2001100338A4 (en)	2001-10-04	Sunglove
AU2001100214A4 (en)	2001-08-30	Dolly-trolley
AU2001100522A4 (en)	2001-11-22	e-Trans
AU2001100532A4 (en)	2001-11-29	FonePark
AU2002100746A4 (en)	2003-05-29	Adrail

Legal Events

Date	Code	Title	Description
2004-07-22	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase